(Q38339763)

2 September 2017

title

Combination therapy of cyclosporine and anti-tumor necrosis factor α in psoriasis: a case series of 10 patients (English)

1 reference

2 September 2017

1 reference

Eran Cohen Barak

1

1 reference

2 September 2017

Miryam Kerner

series ordinal

2

1 reference

2 September 2017

Dganit Rozenman

series ordinal

3

1 reference

2 September 2017

Michael Ziv

series ordinal

4

1 reference

2 September 2017

language of work or name

1 reference

30 January 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

28

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

126-130

1 reference

Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment

2 September 2017

cites work

1 reference

The use of cyclosporine in dermatology: part I.

21 January 2018

1 reference

Systemic treatments for severe pediatric psoriasis: a practical approach

21 January 2018

1 reference

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

21 January 2018

1 reference

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease

21 January 2018

1 reference

A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis.

21 January 2018

1 reference

A clinical trial of combination therapy with etanercept and low dose cyclosporine for the treatment of refractory psoriasis

21 January 2018

1 reference

Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DTH.12196

1 reference

2 September 2017

1 reference